aurora-biopharma.com
Home PageAurora is developing first-in-class therapies for resistant life-threatening solid tumor. Aurora is developing first-in-class therapies for resistant life-threatening solid tumor. Aurora is developing first-in-class therapies for resistant life-threatening solid tumor. Aurora is developing first-in-class therapies for resistant life-threatening solid tumor. Aurora presents at 2016 Bio International Annual Convention San Francisco, CA June 6, 2016. One Mifflin Place, Suite 400. Cambridge, MA 02138.
http://www.aurora-biopharma.com/